EP 0904069 A4 20060823 - PLA2 INHIBITORS OF ANGIOGENESIS
Title (en)
PLA2 INHIBITORS OF ANGIOGENESIS
Title (de)
PLA2 INHIBITOREN VON ANGIOGENESE
Title (fr)
INHIBITEURS PLA2 DE L'ANGIOGENESE
Publication
Application
Priority
- US 9704876 W 19970326
- US 1424496 P 19960326
Abstract (en)
[origin: WO9735567A1] The present invention is to the novel use of a PLA2 inhibitor for the treatment of chronic diseases which are caused by excessive, undesired or inappropriate angiogenesis.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/135 (2006.01); A61K 31/165 (2006.01); A61K 31/195 (2006.01); A61K 31/196 (2006.01); A61K 31/198 (2006.01); A61K 31/27 (2006.01); A61K 45/00 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 27/00 (2006.01); A61P 27/02 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/196 (2013.01); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 27/00 (2017.12); A61P 27/02 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
- [A] WO 9533461 A1 19951214 - SMITHKLINE BEECHAM CORP [US], et al
- [A] WO 9500649 A1 19950105 - SMITHKLINE BEECHAM PLC [GB], et al
- See references of WO 9735567A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9735567 A1 19971002; EP 0904069 A1 19990331; EP 0904069 A4 20060823; JP 2000507946 A 20000627
DOCDB simple family (application)
US 9704876 W 19970326; EP 97917625 A 19970326; JP 53459097 A 19970326